2025 Mid-Year Myeloma Review with Paul Richardson, MD, Dana Farber Cancer Institute

2025 Mid-Year Myeloma Review with Paul Richardson, MD, Dana Farber Cancer Institute

Minimal Residual Disease (MRD) Testing with Dr. Rafael Fonseca

Preventing Myeloma Progression with Diet: The Nutrivention-2 Stu

The Future of Bispecific Antibodies with Dr. Philippe Moreau

A Look into the 2025 Multiple Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson Cancer Center

Driving New Discoveries in Myeloma Research with Dr. Brian Van Ness from the University of Minnesota

2024 Mid-Year Myeloma Review with Paul Richardson, MD, Dana Farber Cancer Institute

The Latest in Amyloidosis Care and Research with Morie Gertz, MD, Mayo Clinic

Creating a Risk Profile to Personalize Myeloma Care with Ola Landgren, MD, PhD, University of Miami

Using all the Myeloma Tools in the Toolbox with Clifton Mo, MD, Dana Farber Cancer Institute

Alfred Garfall, MD and Bea Razzo, MD on Bispecific Antibodies in Multiple Myeloma

The 2024 Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson

Today's CAR T Options in Multiple Myeloma Care with Luciano Costa, MD, UAB

Multiple myeloma mid-year progress with Dr. Paul Richardson of Dana Farber

Stem Cell Transplant Advances and Use in the Age of Immunotherapy

Essential Research for Myeloma Cures with Faith Davies, NYU

The Utility of MRD Testing for Myeloma Patient Treatment and Outcomes

Understanding Blood-Based Testing in Multiple Myeloma with Ola Landgren, MD, PhD

A New "Moda" Targeting CD38 in Multiple Myeloma with Noa Biran, MD, John Theurer